3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Colonic Neoplasms
2
Carcinoma, Hepatocellular
2
Venous Thrombosis
1
Thrombosis
1
Thromboembolism
1
Stomach Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Neoplasms
1
Lung Neoplasms
1
Inflammation
1
Immune System Diseases
1
Gastrointestinal Stromal Tumors
1
Gallbladder Neoplasms
1
Esophageal Neoplasms
1
Duodenal Neoplasms
1
Cholangiocarcinoma
1
Cardiovascular Diseases
1
Breast Neoplasms
1
Biliary Tract Neoplasms
1
Interventions
palbociclib
2
montelukast
1
ginger extract
1
Weights and Measures
1
Vitamin D
1
Tablets
1
Sufentanil
1
Rivaroxaban
1
Oxycodone
1
Omeprazole
1
Morphine
1
Lidocaine
1
Ibuprofen
1
Hyperspectral Imaging
1
Fish Oils
1
Eating
1
Diet Records
1
Dexmedetomidine
1
Dexlansoprazole
1
Calcium
1
CHR 2845
1
Body Height
1
Blood Specimen Collection
1
Bevacizumab
1
Basal Metabolism
1
Aspirin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Inflammation
×
Rivaroxaban
×
Gastrointestinal
×
Clear all
NCT06065592
2023-10-06
CAT_PB
Lebanese University
Phase 1
Unknown
500 enrolled